-
The control group got an injectable dose of Rocephin, a Hoffmann-La Roche drug widely used against meningitis.
FORBES: Magazine Article
-
Meanwhile, Roche spinoff Basilea, developing a successor to Rocephin, touts its new drug, ceftobiprole, against drug-resistant staph infections.
FORBES: On The Cover/Top Stories
-
Worse, it could lose its top seller, the antibiotic Rocephin, to patent expiration in the next several years.
FORBES: Novartis CEO Plays Waiting Game
-
Those kids got 100mg of Rocephin on the first day but only one-third of that dose each of the next four days.
FORBES: Magazine Article
-
Parents of the dead children in the Rocephin group argue their children would have lived had Pfizer given them the full dose.
FORBES: Magazine Article
-
Roche's second-biggest-selling drug, the antibiotic Rocephin, loses patent protection in 2005.
FORBES: Magazine Article
-
Pfizer argues that Rocephin injections can be painful.
FORBES: Magazine Article